<DOC>
	<DOCNO>NCT01447719</DOCNO>
	<brief_summary>This study design test relationship measurement brain amyloid use florbetapir F 18 PET image true level amyloid plaque density measure histopathological assessment . The study address follow specific aim : 1 . To expand number subject include A07 ( NCT00857415 ) trial correlation analysis ( measure correlation global visual rating brain amyloid plaque density independent blind read florbetapir F 18 PET scan cortical amyloid plaque density autopsy assess histopathology subject autopsy cohort ) . 2 . To determine sensitivity specificity independent blind visual read assessment florbetapir F 18 PET scan ( Aβ+ Aβ- ) versus final blind neuropathological assessment make autopsy .</brief_summary>
	<brief_title>Autopsy Follow-up Subjects Previously Imaged With Florbetapir F 18 ( 18F-AV-45 ) PET Trial 18F-AV-45-A07</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Subjects enrol study : Met entrance criterion enrol imaged trial 18FAV45A07 ( NCT00857415 ) Gave inform consent 18FAV45A07 ( NCT00857415 ) study procedure brain donation consistent legal requirement State enrol State die Consent participate 18FAV45A16 ( NCT01447719 ) extension protocol , require IRB Reconfirm consent research brain autopsy , require IRB .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>